U.S. Women's Health Market Size, Share & Trends Analysis Report 2024-2030: Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, PCOS
September 20, 2024 04:04 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Endometriosis & Uterine Fibroids), By Age (50...
United States Endometriosis and Uterine Fibroids Markets, 2020-2024 & 2025-2030: Rise in Non-Invasive Drug Therapies Driving Growth, Online Pharmacies Set to Revolutionize Distribution
September 19, 2024 07:25 ET
|
Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "United States Endometriosis and Uterine Fibroids Market (2024 Edition): Analysis By Drug Type, By Route of Administration, By Distribution Channel, By...
Women's Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030) Featuring Profiles of Amgen, Teva Pharma, Merck & Co, Bayer, AbbVie
September 18, 2024 04:14 ET
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Women Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's...
Endometriosis Drug Pipeline Landscape 2024: Insights About 15+ Companies and 20+ Pipeline Drugs
June 17, 2024 06:54 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Endometriosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Ovarian Cancer Pipeline Drugs Analysis, 2024: Insights on 180+ Companies and 200+ Pipeline Drugs, Including Atezolizumab (Genentech), Tisotuma Vedotin (Genmab), and SON-1010 (Sonnet Biotherapeutics)
June 10, 2024 10:11 ET
|
Research and Markets
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Ovarian Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
National Poll Shows Women Are Missing Out on Vacations, Work, and Social Events Due to Gynecological Conditions
May 02, 2024 10:00 ET
|
LevLane
PHILADELPHIA, May 02, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising, one of Philadelphia's oldest independent full-service advertising agencies, today released the findings of a women's health survey...
Gynecological Devices Market Analysis 2024-2033: Robotic Surgery, AI Diagnostics, and Minimally Invasive Procedures Reshape the $12.44 Billion Industry
January 24, 2024 13:48 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Gynecological Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Gynecological Devices Market...
Global $67B+ Women's Health Market Landscape 2024-2030: Analysis by Age, Application and Region
January 11, 2024 12:43 ET
|
Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Women's Health Market Size, Share & Trends Analysis Report by Application (Postmenopausal Osteoporosis, Infertility, Endometriosis &...
Recent Lancet Study Highlights Potential for Increased Emergency Contraception Efficacy - A Glimpse into the Flourishing Global Contraceptive Market
October 04, 2023 12:18 ET
|
Research and Markets
Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- A groundbreaking discovery, as reported by the medical journal Lancet, has brought to light that combining a common arthritis drug with the morning-after...
Dysmenorrhea Treatment Market to Surpass US$ 13,906.5 million by 2033, Fueled by Growing Incidence of Dysmenorrhea and Development of Novel Therapies | FMI
September 13, 2023 12:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 13, 2023 (GLOBE NEWSWIRE) -- During the historical period between 2018 and 2022, the adoption of dysmenorrhea treatments globally grew at an average annual growth rate of 5.4%. In...